Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis
Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis
About this item
Full title
Author / Creator
Publisher
London, England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
London, England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Psoriasis is a systemic inflammatory disease associated with numerous comorbidities and a profound impact on patients’ quality of life. While its complex immune pathogenesis is still not fully delineated, current evidence supports a fundamental role of the T-helper-17 (TH-17) pathway and its related interleukin-17 (IL-17) cytokine. Thus, new antips...
Alternative Titles
Full title
Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5761942
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5761942
Other Identifiers
ISSN
2040-6223
E-ISSN
2040-6231
DOI
10.1177/2040622317738910
